Atrasentan, also known as ABT-627, is a orally available ETA receptor antagonist with potential antineoplastic activity. As a selective antagonist of the endothelin-A (ETA) receptor, atrasentan binds selectively to the ETA receptor, which may result in inhibition of endothelin-induced angiogenesis and tumor cell proliferation.
Molecular Weight:
532.61
CAS Number:
[178738-96-0]
Formula:
C29H37N2NaO6
Target:
Endothelin Receptor|||Others
T70198
* VAT and and shipping costs not included. Errors and price changes excepted
